US Edition
Published • loading... • Updated
West Pharma CEO Eric Green to Retire After 11 Years at the Helm
Eric M. Green will retire after leading West Pharmaceutical to double sales and a 350% shareholder return during his 11-year tenure, with transition planned for late 2026.
- West Pharmaceutical Services said in a March 9, 2026 press release that Eric M. Green informed the Board he plans to retire once a successor is hired.
- Eric M. Green said, 'After serving 11 years as the Company's 6th CEO over the past century, it is time for someone else to take over the leadership of West', and the staged retirement allows him to pursue future board and advisory roles.
- The Board highlighted Green's tenure, during which he has served as CEO since April 2015 and became Chair in May 2022, with sales more than doubling and a total shareholder return of roughly 350%.
- The Board engaged a leading executive recruiting firm to lead the search and expects the CEO transition in the second half of 2026.
- With over 10,000 team members across 50 sites and delivering over 41 billion components annually, West plays a key role in the pharmaceutical supply chain.
Insights by Ground AI
26 Articles
26 Articles
The Courier-Tribune+24 Reposted by 24 other sources
Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc.
EXTON, Pa., March 9, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that Eric M. Green has informed the Board of Directors that he plans to retire from his positions as President, Chief Executive Officer and Chair…
Coverage Details
Total News Sources26
Leaning Left2Leaning Right2Center7Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
L 18%
C 64%
R 18%
Factuality
To view factuality data please Upgrade to Premium
